---
figid: PMC5337359__PPAR2017-5879090.001
figlink: /pmc/articles/PMC5337359/figure/fig1/
number: Figure 1
caption: 'A model of interactions between the canonical Wnt/beta-catenin pathway and
  PPAR gamma under aerobic glycolysis conditions in colon cancer. In the absence of
  the Wnt ligand (“off state”), cytosolic beta-catenin is phosphorylated by GSK-3
  beta. APS and AXIN combine with GSK-3 beta and beta-catenin to enhance the destruction
  process in the proteasome (beta-catenin proteasomal degradation: CPD). In the presence
  of the Wnt ligand (“on state”), Wnt binds both Frizzled and LRP5/6 receptors to
  initiate LRP phosphorylation and dishevelled-mediated Frizzled internalization.
  This leads to dissociation of the AXIN/APC/GSK-3 beta complex. Beta-catenin phosphorylation
  is inhibited. Thus, beta-catenin accumulates in the cytosol and then translocates
  to the nucleus to bind TCF-LEF cotranscription factors, which induce the Wnt-response
  gene transcription (PDK, MCT-1, cMyc, and cyclin D1). Glucose itself activates the
  Wnt pathway. PPAR gamma via APC activates CPD. PPAR gamma inhibits the beta-catenin-TCF/LEF
  complex. Beta-catenin binds PPAR gamma CBD. PDK inhibits the PDH complex in mitochondria.
  Thus pyruvate cannot be converted into acetyl-CoA and enters the TCA cycle. Myc
  activates LDH-A which converts cytosolic pyruvate into lactate. MCT-1 favors lactate
  secretion from the cytosol which favors angiogenesis. cMyc increases glutamine entry
  in the cytosol and mitochondria. Myc-induced glutamine enhances nucleotide synthesis.
  Abbreviations are as follows: adenomatous polyposis coli (APC); alpha ceto-glutarate
  (a-KG); beta-catenin proteasomal degradation: CPD; catenin binding domain (CBD);
  Dishevelled (Dsh); Frizzled (Fzd); glycogen synthase kinase-3beta (GSK-3beta); lactate
  dehydrogenase (LDH); low-density lipoprotein receptor-related protein 5/6 (LRP5/6);
  monocarboxylate lactate transporter-1 (MCT-1); peroxisome proliferator-activated
  receptor gamma (PPAR gamma); pyruvate dehydrogenase complex (PDH); pyruvate dehydrogenase
  kinase (PDK); T-cell factor/lymphoid enhancer factor (TCF/LEF); tricarboxylic acid
  (TCA); ∗: Wnt targets: PDK, cMyc, MCT-1, and cyclin D1.'
pmcid: PMC5337359
papertitle: Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway
  in Type 2 Diabetes and Colon Cancer.
reftext: Yves Lecarpentier, et al. PPAR Res. 2017;2017:5879090.
pmc_ranked_result_index: '31459'
pathway_score: 0.9657499
filename: PPAR2017-5879090.001.jpg
figtitle: Interactions between the canonical Wnt/beta-catenin pathway and PPAR gamma
  under aerobic glycolysis conditions in colon cancer
year: '2017'
organisms: Homo sapiens
ndex: 5e5dbad4-deb1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5337359__PPAR2017-5879090.001.html
  '@type': Dataset
  description: 'A model of interactions between the canonical Wnt/beta-catenin pathway
    and PPAR gamma under aerobic glycolysis conditions in colon cancer. In the absence
    of the Wnt ligand (“off state”), cytosolic beta-catenin is phosphorylated by GSK-3
    beta. APS and AXIN combine with GSK-3 beta and beta-catenin to enhance the destruction
    process in the proteasome (beta-catenin proteasomal degradation: CPD). In the
    presence of the Wnt ligand (“on state”), Wnt binds both Frizzled and LRP5/6 receptors
    to initiate LRP phosphorylation and dishevelled-mediated Frizzled internalization.
    This leads to dissociation of the AXIN/APC/GSK-3 beta complex. Beta-catenin phosphorylation
    is inhibited. Thus, beta-catenin accumulates in the cytosol and then translocates
    to the nucleus to bind TCF-LEF cotranscription factors, which induce the Wnt-response
    gene transcription (PDK, MCT-1, cMyc, and cyclin D1). Glucose itself activates
    the Wnt pathway. PPAR gamma via APC activates CPD. PPAR gamma inhibits the beta-catenin-TCF/LEF
    complex. Beta-catenin binds PPAR gamma CBD. PDK inhibits the PDH complex in mitochondria.
    Thus pyruvate cannot be converted into acetyl-CoA and enters the TCA cycle. Myc
    activates LDH-A which converts cytosolic pyruvate into lactate. MCT-1 favors lactate
    secretion from the cytosol which favors angiogenesis. cMyc increases glutamine
    entry in the cytosol and mitochondria. Myc-induced glutamine enhances nucleotide
    synthesis. Abbreviations are as follows: adenomatous polyposis coli (APC); alpha
    ceto-glutarate (a-KG); beta-catenin proteasomal degradation: CPD; catenin binding
    domain (CBD); Dishevelled (Dsh); Frizzled (Fzd); glycogen synthase kinase-3beta
    (GSK-3beta); lactate dehydrogenase (LDH); low-density lipoprotein receptor-related
    protein 5/6 (LRP5/6); monocarboxylate lactate transporter-1 (MCT-1); peroxisome
    proliferator-activated receptor gamma (PPAR gamma); pyruvate dehydrogenase complex
    (PDH); pyruvate dehydrogenase kinase (PDK); T-cell factor/lymphoid enhancer factor
    (TCF/LEF); tricarboxylic acid (TCA); ∗: Wnt targets: PDK, cMyc, MCT-1, and cyclin
    D1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYC
  - CTNNB1
  - AXIN2
  - AXIN1
  - FZD8
  - CPD
  - OPN1MW
  - PDK1
  - CCND1
  - FZD9
  - FZD7
  - WNT10B
  - PDHA1
  - PDHA2
  - WNT8B
  - APC
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - LDHA
  - LRP5
  - FZD10
  - FZD2
  - DLD
  - FZD5
  - FZD3
  - PDHB
  - PDHX
  - FZD6
  - PDK3
  - WNT11
  - WNT2B
  - PDK2
  - WNT4
  - WNT1
  - FZD1
  - WNT9A
  - WNT5A
  - WNT16
  - LRP6
  - FZD4
  - DLAT
  - WNT3A
  - WNT9B
  - MCTS1
  - WNT5B
  - PDK4
  - WNT3
  - WNT10A
  - WNT2
  - Aspartate
  - Glucose
  - Glutamine
  - Pyruvate
  - Lactate
  - Cancer
genes:
- word: cMyc*
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: CPD
  symbol: CPD
  source: hgnc_symbol
  hgnc_symbol: CPD
  entrez: '1362'
- word: CBD
  symbol: CBD
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1MW
  entrez: '2652'
- word: PDK*
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: cyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: LDH-A*.
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: PDK*
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: PDK*
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: -PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: MCT-1
  symbol: MCT-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCTS1
  entrez: '28985'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: PDK*
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
chemicals:
- word: Aspartate
  source: MESH
  identifier: D001224
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glutamine
  source: MESH
  identifier: D005973
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Lactate
  source: MESH
  identifier: D019344
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
